Sign in

NCT07387575Enrolling by invitation

Screening in Relatives With Elevated Risk for Unruptured Intracranial Aneurysms

Screening for Intracranial Unruptured Aneurysms in First-Degree Relatives of Patients With Aneurysmal Subarachnoid Hemorrhage

Source: ClinicalTrials.gov · Last updated 4 Feb 2026

Brief summary (registry, in English)

The purpose of this study is to screen first-degree relatives of patients with aneurysmal subarachnoid hemorrhage using magnetic resonance angiography to detect unruptured intracranial aneurysms. This study aims to identify individuals who are at increased risk and determine the effect of environmental factors for development of unruptured intracranial aneurysms.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
300 (estimated)
First submitted
27 Jan 2026
Start date
1 Feb 2026
Primary completion date
31 Jan 2027
Lead sponsor
University of Novi Sad
Diseases
Stroke
NCT number
NCT07387575

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 1 Feb 2026 to the primary completion date, 31 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of intracranial aneurysm rupture or prior subarachnoid hemorrhage;
  • Contraindications to MRI/MRA (e.g., pacemaker, metallic implants, severe claustrophobia) or pregnancy (due to MRI safety considerations);

Other illness

  • A history of polycystic kidney disease, Marfan's Syndrome, Ehlers Danlos Syndrome, or fibromuscular dysplasia;

Other

  • Unable or unwilling to provide informed consent;
  • Participation in another interventional study that could interfere with outcomes.

Who the study is looking for

  • First-degree relatives (parents, siblings, or children) of patients diagnosed with aneurysmal subarachnoid hemorrhage (aSAH);
  • Age ≥ 30 years at the time of enrollment, and current cigarette smokers or diagnosed with hypertension (either treated or untreated);
  • Able and willing to undergo magnetic resonance angiography (MRA);
    • 5\. Able to provide written informed consent; 6. Sporadic aneurysm subjects must have a confirmed UIAs

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University Clinical Center of Vojvodina
Coordinator of this site? Confirm its status
Novi SadSerbiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.